Location · Cincinnati, OH
Clinical trials in Cincinnati, OH
344 recruiting studies have a site in the Cincinnati area, and 80 of them accept healthy volunteers. The area includes Mason, West Chester, Fairfield, Blue Ash, Hamilton, Middletown and nearby cities.
344 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingHealthy volunteersPhase 3
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
GlaxoSmithKline
- Location
- Huntington Park, CA + 14 other US sites
- Eligibility basics
- Ages 1–1
- RecruitingHealthy volunteers
Helix Research Network
Helix, Inc
- Location
- Fort Wayne, IN + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
A Study to Evaluate the SENSE Device's Ability to Detect TBI
Sense Diagnostics, LLC
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Ages 22+
- RecruitingHealthy volunteers
The DistaSense VITALS Study
Life Detection Technologies
- Location
- St Louis, MO + 1 other US site
- Eligibility basics
- Ages 22+
- RecruitingHealthy volunteers
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Corvivo Cardiovascular, Inc.
- Location
- Mobile, AL + 3 other US sites
- Eligibility basics
- Ages 1–85
- RecruitingPhase 3
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Washington D.C., DC + 5 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Birmingham, AL + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Takeda
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- Phoenix, AZ + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Astellas Institute for Regenerative Medicine
- Location
- Phoenix, AZ + 3 other US sites
- Eligibility basics
- Ages 6+
- Recruiting
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
SeaStar Medical
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Xinnate AB
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 4+
- RecruitingPhase 3
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Amicus Therapeutics
- Location
- Atlanta, GA + 5 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Apogee Therapeutics, Inc.
- Location
- Fountain Valley, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
Orchestra BioMed, Inc
- Location
- Phoenix, AZ + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Regeneron Pharmaceuticals
- Location
- La Mesa, CA + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
Peptilogics
- Location
- Sarasota, FL + 13 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Vima Therapeutics
- Location
- Birmingham, AL + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2/Phase 3
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
BioMarin Pharmaceutical
- Location
- Oakland, CA + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- Phoenix, AZ + 58 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
CVRx, Inc.
- Location
- Mobile, AL + 16 other US sites
- Eligibility basics
- Ages 18+